Demuris Limited

Active06255507 Private limited company
Incorporated
22 May 2007 (19 years)
Previously known as
Nugenis Limited (until 10 October 2008)
Norham House 1120 Limited (until 28 August 2007)
Industry
Research and experimental development on biotechnology (72110)
Directors
Owned by
Odyssey Therapeutics, Inc.
Accounts type
Full
Region
East Midlands
Address
3 Weekley Wood Close
Kettering
NN14 1UQ

Filing status

Accounts due
30 September 2026
Last accounts
30 December 2024
Conf. stmt due
5 June 2027
Last conf. stmt
22 May 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 1 active

Officer details are public data from the Companies House register.

Director · Appointed 30 August 2021
American
Born June 1961 (65)
Officer history (14 former)
8 May 2026
Resigned Gordon, Carl Lee as Director
20 March 2024
Resigned Gordon, Carl Lee as Director
12 March 2024
Resigned Odegard, Valerie, Dr as Director
12 March 2024
Resigned Baum, Charles as Director
12 March 2024
Resigned Carroll, Jill Anne, Ms. as Director
26 August 2022
Resigned F.E.Laughlin Ltd as Corporate Secretary
30 August 2021
Resigned Pompliano, David Leo as Director
30 August 2021
Appointed Baum, Charles as Director
30 August 2021
Appointed Odegard, Valerie, Dr as Director
30 August 2021
Appointed Gordon, Carl Lee as Director
30 August 2021
Appointed Carroll, Jill Anne, Ms. as Director
30 August 2021
Resigned Errington, Jeffery as Director
30 August 2021
Resigned Matthews, David Glyn as Director
30 August 2021
Appointed Gordon, Carl Lee as Director
30 August 2021
Appointed Glick, Gary D. as Director
1 September 2019
Appointed Pompliano, David Leo as Director
1 September 2019
Appointed Matthews, David Glyn as Director
22 July 2019
Resigned Baxter, Anthony David, Dr as Director
2 March 2017
Appointed Baxter, Anthony David, Dr as Director
31 March 2016
Resigned Elstob, Philip Ronald, Dr as Director
12 November 2013
Appointed Elstob, Philip Ronald, Dr as Director
31 December 2012
Resigned Lockwood, Robin Jeremy as Director
7 October 2010
Appointed Lockwood, Robin Jeremy as Director
14 May 2010
Appointed F.E.Laughlin Ltd as Corporate Secretary
13 May 2010
Resigned Muckle Secretary Limited as Corporate Secretary
3 September 2007
Appointed Errington, Jeffery as Director
22 August 2007
Resigned Norham House Director Limited as Corporate Director
22 May 2007
Appointed Norham House Director Limited as Corporate Director
22 May 2007
Appointed Muckle Secretary Limited as Corporate Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Odyssey Therapeutics, Inc.
Corporate entity · Notified 30 August 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Right to appoint and remove directors (as a firm)
Delaware Corporation
Reg. no. N/A
Former controllers (2)
30 August 2021
Ceased Newcastle University Holdings Limited — Owns 25–50% of shares
30 August 2021
Ceased Jeffery Errington — Owns 25–50% of shares

Financials

Balance sheet as at 30 December 2024 · full accounts

Net Assets
£14,211
Cash
£69,131
Turnover
£13,047
Profit Before Tax
£3,195
Current Ratio
1.2x
Profit Margin
24%
Return on Equity
22%

Trend

Turnover
£0 £500k £1.0M £1.5M £2.0M 2021 2022 2023 2024 £279,799 £1,552,614 £91,617 £13,047
Balance sheet detail
202420232022202120212020
Fixed Assets£0£77,369£8,058£9,049
Current Assets£74,411£173,649£201,182£332,204£18,360£153,858
Debtors£5,280£5,828£190,460£252,431£17,716£40,045
Cash£69,131£167,821£10,722£57,064£644£113,813
Creditors (< 1 year)£60,200£162,632£41,385£517,998£50,082£61,592
Creditors (> 1 year)£236,000
Net Current Assets£14,211£11,017£159,797(£185,794)(£31,722)£92,266
Net Assets£14,211£11,017£27,983(£344,425)(£23,664)£101,315
Shareholder Funds£14,211£11,017£27,983(£344,425)(£23,664)£101,315

Turnover£13,047£91,617£1,552,614£279,799
Cost of Sales£0£38,401£212,526
Gross Profit£13,047£53,216£1,340,088
Admin Expenses£9,855£70,335£898,063£494,269
Operating Profit£3,192(£17,176)£435,188(£149,196)
Profit Before Tax£3,195(£16,966)£372,409(£385,196)
Tax£1£0£0(£32,276)
Profit for Period£3,194(£16,966)£372,409(£352,920)

Filings 107

DateDescriptionMade Up ToPagesPDF
1 October 2026Termination of appointment of a director
29 May 2026Confirmation statement with no updates22 May 2026
25 November 2025Registered office address changed
29 September 2025Full accounts30 December 2024
22 May 2025Confirmation statement with no updates22 May 2025
Show all 107 filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?